Our Regulatory Pathway Analysis service for medical devices helps manufacturers navigate the complex landscape of device approvals. We provide clear regulatory strategy for FDA 510(k), PMA, De Novo, CE marking, and global regulatory pathways. Our team assesses device classification, identifies predicate devices, and develops submission strategies.
How our regulatory pathway analysis service delivers value to your organization.
Identification of the most efficient regulatory pathway based on device classification, risk level, and predicate availability.
Comprehensive submission strategy including content requirements, testing plans, and agency interaction timelines.
Identification and analysis of predicate devices for 510(k) submissions with comparison testing requirements.
Regulatory pathway mapping across US, EU, Japan, and emerging markets for coordinated global submissions.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Determine device classification and applicable regulatory requirements across target markets.
Select the optimal regulatory pathway based on risk level, predicate availability, and market priorities.
Develop detailed submission plan with content requirements, testing needs, and agency interactions.
Support submission preparation, agency interactions, and response to additional information requests.
We assess device classification, risk level, predicate device availability, intended use, and technological characteristics to recommend the most efficient pathway (510(k), De Novo, or PMA).
Yes, we support CE marking submissions including technical file preparation, conformity assessment, and Notified Body interactions.
Yes, we prepare pre-submission packages, develop meeting agendas, and provide strategic guidance for FDA and Notified Body interactions.
Comprehensive competitive landscape analysis with feature comparison, pricing benchmarks, and market share assessment.
Learn moreMarket entry strategy across US, EU, Japan, and emerging markets with reimbursement and pricing optimization.
Learn moreClinical trial design and evidence generation strategy tailored to regulatory requirements and payer expectations.
Learn moreConnect with our team to discuss how our regulatory pathway analysis service can support your goals.
Schedule a Consultation